Mycapssa 20 mg/1
Octreotide · CAPSULE, DELAYED RELEASE · Amryt Pharmaceuticals Designated Activity Company
Mycapssa is a capsule, delayed release containing octreotide at 20 mg/1, taken oral. Manufactured by Amryt Pharmaceuticals Designated Activity Company.
Key Facts
- Brand Name
- Mycapssa
- Generic Name
- Octreotide
- NDC Code (Product)
69880-120- Manufacturer
- Amryt Pharmaceuticals Designated Activity Company
- Strength
- 20 mg/1
- Dosage Form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA208232
- Drug Class
- Somatostatin Analog [EPC]
- Marketing Start
- 07/06/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Mycapssa used for?
Mycapssa contains Octreotide. It is a capsule, delayed release taken oral. Consult your doctor for specific uses.
Is Mycapssa a controlled substance?
Mycapssa is not classified as a controlled substance by the DEA.
What is the generic name for Mycapssa?
The generic name for Mycapssa is Octreotide. There are 11 other brand versions of Octreotide.
What is the NDC code for Mycapssa 20 mg/1?
The NDC (National Drug Code) for Mycapssa 20 mg/1 is 69880-120, listed by Amryt Pharmaceuticals Designated Activity Company.
Other Mycapssa Dosages
Other Octreotide Brands
See all →- OCTREOTIDE ACETATE50 ug/mL23155-687
- Octreotide Acetate1000 ug/mL25021-467
- Octreotide Acetate50 ug/mL71288-566
- Octreotide Acetate100 ug/mL0641-6175
- Octreotide Acetate1000 ug/mL0641-6178
- Sandostatin LAR Depot0078-0825
- Octreotide Acetate500 ug/mL68083-560
- Sandostatin50 ug/mL0078-0180
- Octreotide Acetate0480-9259
- Octreotide Acetate500 ug/mL0641-6176
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)